Xionghua Wu - Concepedia

Author

Xionghua Wu

AstraZeneca (United States)

Also Known As

X W Wu, Xionghua W. Wu, Xionghua Wilson Wu, Xionghua Wu

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

AstraZeneca (United States)Beth Israel Deaconess Medical Center Fred Hutch Cancer Center Halozyme Therapeutics (United States)Medical College of Wisconsin

About

Xionghua Wu is an author at AstraZeneca (United States) specializing in medicine, virology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	508
2	Health Sciences	3	3	217
3	Public Health	2	2	49
4	Epidemiology	2	2	49
5	Diagnostic Sciences	1	1	35

Xionghua Wu

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
The test-negative design: validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomised placebo-controlled clinical trials Gaston De Serres, Danuta M. Skowronski, Xionghua Wu, Eurosurveillance	2013	254
Cardiopulmonary Exercise Testing and Six-Minute Walk Correlations in Pulmonary Arterial Hypertension Ronald J. Oudiz, Robyn J. Barst, James E. Hansen, The American Journal of Cardiology HypertensionPhysical ActivityKinesiologySix-minute Walk CorrelationsPulmonary Arterial Hypertension	2005	157
Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity Robert B. Belshe, Kathleen Coelingh, Christopher S. Ambrose, Vaccine VaccinationAntigenic SimilarityVaccine DevelopmentVaccine TargetImmunology	2009	140
The role of nasal IgA in children vaccinated with live attenuated influenza vaccine Christopher S. Ambrose, Xionghua Wu, Taff Jones, Vaccine	2012	113
Respiratory Syncytial Virus Disease in Preterm Infants in the US Born at 32–35 Weeks Gestation Not Receiving Immunoprophylaxis Christopher S. Ambrose, Evan J. Anderson, Eric A. F. Simões, The Pediatric Infectious Disease Journal	2013	88
Distribution of Respiratory Syncytial Virus Subtypes A and B Among Infants Presenting to the Emergency Department With Lower Respiratory Tract Infection or Apnea Hasan S. Jafri, Xionghua Wu, Doris Makari, The Pediatric Infectious Disease Journal	2013	72
High response rate and PFS with PEGPH20 added to nab-paclitaxel/gemcitabine in stage IV previously untreated pancreatic cancer patients with high-HA tumors: Interim results of a randomized phase II study. Sunil R. Hingorani, William Proctor Harris, Andrew Hendifar, Journal of Clinical Oncology Cancer ManagementPharmacotherapyTumor BiologyPancreatic Cancer PatientsChemotherapy Perfusion	2015	58
The Efficacy of Live Attenuated and Inactivated Influenza Vaccines in Children as a Function of Time Postvaccination Christopher S. Ambrose, Xionghua Wu, Robert B. Belshe The Pediatric Infectious Disease Journal	2010	55
Randomized phase II study of PEGPH20 plus nab-paclitaxel/gemcitabine (PAG) vs AG in patients (Pts) with untreated, metastatic pancreatic ductal adenocarcinoma (mPDA). Sunil R. Hingorani, Andrea J. Bullock, Tara Elisabeth Seery, Journal of Clinical Oncology PathologyPhase Ii StudyPharmacotherapyThrombosisVs Ag	2017	35
The Underrecognized Burden of Respiratory Syncytial Virus Among Infants Presenting to US Emergency Departments Doris Makari, Mary Allen Staat, Kelly J. Henrickson, Clinical Pediatrics AsthmaUs Emergency DepartmentsRespiratory Virus ImmunityVirus EpidemiologyViral Diagnostics	2014	32

Page 1